SAB3500946
Anti-HIV-1 P24 antibody produced in rabbit
affinity isolated antibody
Sign Into View Organizational & Contract Pricing
Select a Size
About This Item
UNSPSC Code:
12352203
NACRES:
NA.41
biological source
rabbit
Quality Level
conjugate
unconjugated
antibody form
affinity isolated antibody
antibody product type
primary antibodies
clone
polyclonal
form
buffered aqueous solution
mol wt
predicted mol wt 24 kDa
species reactivity
virus
concentration
1 mg/mL
technique(s)
ELISA: suitable
immunoblotting: suitable
NCBI accession no.
UniProt accession no.
shipped in
wet ice
storage temp.
−20°C
target post-translational modification
unmodified
General description
P24 is a free HIV capsid antigen. This antigen forms a part of inner shell of the virus. Less amount of P24 antigen in the blood shows high amount of P24 antibody.
Immunogen
Antibody was raised against a recombinant full-length HIV-1 p24 protein .
Application
Anti-HIV-1 P24 antibody has been used in western blotting.
Biochem/physiol Actions
P24 antigen test is usually done to evaluate new drugs.
Features and Benefits
Evaluate our antibodies with complete peace of mind. If the antibody does not perform in your application, we will issue a full credit or replacement antibody. Learn more.
Physical form
Supplied at 1 mg/mL in PBS with 0.02% sodim azide.
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Not finding the right product?
Try our Product Selector Tool.
Storage Class Code
10 - Combustible liquids
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Effect of HIV-1 Env on SERINC5 antagonism.
Beitari S, et al.
Journal of Virology, 91(4), e02214-e02216 (2017)
The Essential HIV Treatment Fact Book (1992)
Daniel Y Joh et al.
Advanced healthcare materials, 8(8), e1801177-e1801177 (2019-03-26)
Poly(ethylene glycol) (PEG), a linear polymer known for its "stealth" properties, is commonly used to passivate the surface of biomedical implants and devices, and it is conjugated to biologic drugs to improve their pharmacokinetics. However, its antigenicity is a growing
Catharina E A Lindenburg et al.
Vaccine, 20(17-18), 2343-2347 (2002-05-16)
Long-term effects of therapeutic vaccination of human immunodeficiency virus (HIV)-1-infected subjects with HIV-1 p17/p24:Ty virus-like particles (p24-VLP) on progression to AIDS, death, a CD4 cell count <or=200 cells/mm(3) and CD4 cell count decline were studied in a multicenter cohort study
The V3 loop of HIV-1 Env determines viral susceptibility to IFITM3 impairment of viral infectivity.
Wang Y, et al.
Journal of Virology, 91(7), e02441-e02416 (2017)
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service